Recognizable phenotypes in CDG
- 13 April 2018
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 41 (3), 541-553
- https://doi.org/10.1007/s10545-018-0156-5
Abstract
Pattern recognition, using a group of characteristic, or discriminating features, is a powerful tool in metabolic diagnostic. A classic example of this approach is used in biochemical analysis of urine organic acid analysis, where the reporting depends more on the correlation of pertinent positive and negative findings, rather than on the absolute values of specific markers. Similar uses of pattern recognition in the field of biochemical genetics include the interpretation of data obtained by metabolomics, like glycomics, where a recognizable pattern or the presence of a specific glycan sub-fraction can lead to the direct diagnosis of certain types of congenital disorders of glycosylation. Another indispensable tool is the use of clinical pattern recognition–or syndromology–relying on careful phenotyping. While genomics might uncover variants not essential in the final clinical expression of disease, and metabolomics could point to a mixture of primary but also secondary changes in biochemical pathways, phenomics describes the clinically relevant manifestations and the full expression of the disease. In the current review we apply phenomics to the field of congenital disorders of glycosylation, focusing on recognizable differentiating findings in glycosylation disorders, characteristic dysmorphic features and malformations in PMM2-CDG, and overlapping patterns among the currently known glycosylation disorders based on their pathophysiological basis.Keywords
Funding Information
- National Institute of General Medical Sciences (GM104940)
This publication has 71 references indexed in Scilit:
- Subcutaneous fat pads on body MRI – an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a)Pediatric Radiology, 2013
- Congenital myasthenic syndromes due to mutations inALG2andALG14Brain, 2013
- The Molecular Landscape of Phosphomannose Mutase Deficiency in Iberian Peninsula: Identification of 15 Population-Specific MutationsJIMD Reports, 2011
- Hexosamine Biosynthetic Pathway Mutations Cause Neuromuscular Transmission DefectAmerican Journal of Human Genetics, 2011
- Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis?Molecular Genetics and Metabolism, 2010
- Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia)Journal of Medical Genetics, 2009
- Congenital disorder of glycosylation type Ia in a Malaysian family: Clinical outcome and description of a novel PMM2 mutationJournal of Inherited Metabolic Disease, 2009
- Congenital disorder of glycosylation type Ia presenting with hydrops fetalisJournal of Medical Genetics, 2007
- Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedemaEuropean Journal of Pediatrics, 2005
- Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate‐deficient glycoprotein syndromeJournal of Inherited Metabolic Disease, 1992